ArticleAmerican journal of translational research2025
Epidemiological characteristics of Mycoplasma pneumoniae and viral infections in hospitalized children with recurrent lower respiratory tract infections.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the epidemiological characteristics of Mycoplasma pneumoniae and common viral infections in hospitalized children with recurrent lower respiratory tract infections in Chengdu from 2019 to 2023, and to provide scientific evidence to support clinical diagnosis, treatment, and public health prevention.
methodsA retrospective analysis was conducted on pathogen detection results from 10,580 children hospitalized with recurrent lower respiratory tract infections at a hospital in Chengdu between January 2019 and December 2023.
resultsAmong the 10,580 hospitalized children, the pathogen detection rate was 28.01%, with Mycoplasma pneumoniae showing the highest positivity rate (17.49%). The detection rates of influenza B virus and Mycoplasma pneumoniae were significantly higher in female children compared to males (all P < 0.05). The positivity rates for adenovirus, respiratory syncytial virus, influenza A virus, and human rhinovirus in 2023 were significantly elevated compared to other years (all P < 0.05). In children under 1 year of age, detection rates for influenza A virus, influenza B virus, and Mycoplasma pneumoniae were lower. The co-detection rate of viral infections and Mycoplasma pneumoniae was low (all P < 0.05). A higher detection rate of Mycoplasma pneumoniae was observed in 3-year-olds, along with a higher co-detection rate of two pathogens (all P < 0.05).
conclusionMycoplasma pneumoniae is the predominant pathogen in hospitalized children with recurrent lower respiratory tract infections. Gender, age and season significantly influence pathogen positivity rates. Notably, in 2023, the positivity rates of many pathogens increased significantly, potentially related to changes in COVID-19 prevention and control measures.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.